The FDA approved Tris Pharma’s Onyda XR to treat ADHD in children who are at least 6 years old.
It’s the first liquid non-stimulant ADHD …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact screenings for high blood pressure and Type 1
London-based SPAC Ashington Innovation is planning to acquire dormant, UK-based biotech Celixir for $172 million (£135 million) in an all-share transaction, taking over its lead
Dive Brief: Fresenius Kabi has received a warning letter related to the large-volume infusion pumps that it acquired through its $240 million takeover of Ivenix.